Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
- Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
- Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
- Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
- Transcriptional memory of dFOXO activation in youth curtails later-life mortality
- Gut microbiome drives individual memory variation in bumblebees
- Phosphoproteomic and Metabolomic Profiling Uncovers the Roles of CcPmk1 in the Pathogenicity of <i>Cytospora chrysosperma</i>
- Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
- Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
- PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
- Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui
Observed in differential profiles
- G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
- non_COVID_19_healthy_vs_non_critical_COVID_19
- Control_vs_nsPEF_7_day
- Control_vs_Lithogenic_Diet
- RU-_Control_vs_RU+_Switch
- Hindgut_Control_vs_Lactobacillus_apis
- CcPmk1_vs_Wild_type
- Normal_vs_Neural_Tube_Defect
- Control_vs_CSD
- wild_type_vs_patA_deletion
- Control_vs_BP3_Low_Concentration